<?xml version="1.0" encoding="UTF-8"?>
<p id="Par72">Excluding lost to follow-up and non compliant patients, according to PP-analysis, SVR-12 was achieved in 93/95 (97.9%) in group A versus 34/36 (94.4%) in group B (
 <italic>p</italic> = 0.30).
</p>
